178 related articles for article (PubMed ID: 36272513)
1. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
Zhang C; Bodmeier R
Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
[TBL] [Abstract][Full Text] [Related]
2. Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles.
Zhang C; Bodmeier R
Eur J Pharm Biopharm; 2023 Oct; 191():1-11. PubMed ID: 37579890
[TBL] [Abstract][Full Text] [Related]
3. Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens.
Zhang C; Bodmeier R
Int J Pharm; 2024 Jun; 660():124329. PubMed ID: 38857662
[TBL] [Abstract][Full Text] [Related]
4. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.
Lecaroz C; Gamazo C; Renedo MJ; Blanco-Prieto MJ
J Microencapsul; 2006 Nov; 23(7):782-92. PubMed ID: 17123922
[TBL] [Abstract][Full Text] [Related]
6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
7. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
8. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the properties of glycyrrhetinic acid-loaded PLGA microparticles prepared by emulsion and template methods.
Wang H; Zhang G; Sui H; Liu Y; Park K; Wang W
Int J Pharm; 2015 Dec; 496(2):723-31. PubMed ID: 26581771
[TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
11. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
12. Thermally processed polymeric microparticles for year-long delivery of dexamethasone.
Goodfriend AC; Welch TR; Nguyen KT; Johnson RF; Sebastian V; Reddy SV; Forbess J; Nugent A
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():595-600. PubMed ID: 26478349
[TBL] [Abstract][Full Text] [Related]
13. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
Intra J; Salem AK
J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
[TBL] [Abstract][Full Text] [Related]
14. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
Sharifi F; Otte A; Yoon G; Park K
J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
16. Size effect of PLGA spheres on drug loading efficiency and release profiles.
Dawes GJ; Fratila-Apachitei LE; Mulia K; Apachitei I; Witkamp GJ; Duszczyk J
J Mater Sci Mater Med; 2009 May; 20(5):1089-94. PubMed ID: 19160026
[TBL] [Abstract][Full Text] [Related]
17. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
Garner J; Skidmore S; Hadar J; Park H; Park K; Qin B; Wang Y
J Control Release; 2022 Oct; 350():600-612. PubMed ID: 36057396
[TBL] [Abstract][Full Text] [Related]
18. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
[TBL] [Abstract][Full Text] [Related]
20. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants.
Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A
Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
